SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-16-014989
Filing Date
2016-03-17
Accepted
2016-03-17 16:11:57
Documents
59
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abio-10k_20151231.htm 10-K 1955232
2 EX-23.1 abio-ex231_9.htm EX-23.1 3118
3 EX-31.1 abio-ex311_10.htm EX-31.1 14989
4 EX-31.2 abio-ex312_7.htm EX-31.2 15812
5 EX-32.1 abio-ex321_6.htm EX-32.1 9335
  Complete submission text file 0001564590-16-014989.txt   5700242

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abio-20151231.xml EX-101.INS 991549
7 XBRL TAXONOMY EXTENSION SCHEMA abio-20151231.xsd EX-101.SCH 40115
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20151231_cal.xml EX-101.CAL 34672
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20151231_def.xml EX-101.DEF 125521
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20151231_lab.xml EX-101.LAB 375160
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20151231_pre.xml EX-101.PRE 265955
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 161512678
SIC: 2835 In Vitro & In Vivo Diagnostic Substances